The "50-50 criteria" on postoperative day 5 - An accurate predictor of liver failure and death after hepatectomy

被引:871
作者
Balzan, S
Belghiti, J
Farges, O
Ogata, S
Sauvanet, A
Delefosse, D
Durand, F
机构
[1] Univ Paris 07, Dept Hepatobiliary Surg & Liver Transplantat, Hop Beaujon, F-92118 Clichy, France
[2] Univ Paris 07, Dept Anesthesiol, Hop Beaujon, F-92118 Clichy, France
关键词
D O I
10.1097/01.sla.0000189131.90876.9e
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To standardize the definition of postoperative liver failure (PLF) for prediction of early mortality after hepatectomy. Summary Background Data: The definition of PLF is not standardized, making the comparison of innovations in surgical techniques and the timely use of specific therapeutic interventions complex. Methods: Between 1998 and 2002, 775 elective liver resections, including 69% for malignancies and 60% major resections, were included in a prospective database. The nontumorous liver was abnormal in 43% with steatosis > 30% in 14%, noncirrhotic fibrosis in 43%, and cirrhosis in 12%. The impact of prothrombin time (PT) < 50% and serum bilirubin (SB) > 50 mu mol/L on postoperative days (POD) 1, 3, 5, and 7 was analyzed. Results: The lowest PT level was observed on postoperative day (POD) 1, while the peak of SB was observed on POD 3. These 2 variables tended to return to preoperative values by POD 5. The median interval between hepatectomy and postoperative death was 15 days (range, 5-39 days). Postoperative mortality significantly increased in patients with PT < 50% and SB > 50 mu ml/L. The conjunction of PT < 50% and SB > 50 mu mol/L on POD 5 was a. strong predictive factor of mortality. In patients with significant morbidity, this "50-50 criteria" was met 3 to 8 days before clinical evidence of complications. Conclusions: The association of PT < 50% and SB > 50 mu mol/L on POD 5 (the 50-50 criteria) was a simple, early, and accurate predictor of more than 50% mortality rate after hepatectomy. This criteria could be identified early enough, before clinical evidence of complications, for specific interventions to be applied in due time.
引用
收藏
页码:824 / 829
页数:6
相关论文
共 24 条
  • [1] Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver
    Azoulay, D
    Castaing, D
    Krissat, J
    Smail, A
    Hargreaves, GM
    Lemoine, A
    Emile, JF
    Bismuth, H
    [J]. ANNALS OF SURGERY, 2000, 232 (05) : 665 - 672
  • [2] Hepatic Steatosis as a Potential Risk Factor for Major Hepatic Resection
    Behrns K.E.
    Tsiotos G.G.
    DeSouza N.F.
    Krishna M.K.
    Ludwig J.
    Nagorney D.M.
    [J]. Journal of Gastrointestinal Surgery, 1998, 2 (3) : 292 - 298
  • [3] Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
    Belghiti, J
    Hiramatsu, K
    Benoist, S
    Massault, PP
    Sauvanet, A
    Farges, O
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) : 38 - 46
  • [4] Child C G, 1964, Major Probl Clin Surg, V1, P1
  • [5] Trends in long-term survival following liver resection for hepatic colorectal metastases
    Choti, MA
    Sitzmann, JV
    Tiburi, MF
    Sumetchotimetha, W
    Rangsin, R
    Schulick, RD
    Lillemoe, KD
    Yeo, CJ
    Cameron, JL
    [J]. ANNALS OF SURGERY, 2002, 235 (06) : 759 - 765
  • [6] Preoperative risk assessment of hepatic resection for malignant disease
    Cohnert, TU
    Rau, HG
    Buttler, E
    HernandezRichter, T
    Sauter, G
    Reuter, C
    Schildberg, FW
    [J]. WORLD JOURNAL OF SURGERY, 1997, 21 (04) : 396 - 401
  • [7] Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD
    Durand, F
    Valla, D
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : S100 - S107
  • [8] Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths
    Fan, ST
    Lo, CM
    Liu, CL
    Lam, CM
    Yuen, WK
    Yeung, C
    Wong, J
    [J]. ANNALS OF SURGERY, 1999, 229 (03) : 322 - 330
  • [9] PERIOPERATIVE NUTRITIONAL SUPPORT IN PATIENTS UNDERGOING HEPATECTOMY FOR HEPATOCELLULAR-CARCINOMA
    FAN, ST
    LO, CM
    LAI, ECS
    CHU, KM
    LIU, CL
    WONG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (23) : 1547 - 1552
  • [10] Portal vein embolization before right hepatectomy - Prospective clinical trial
    Farges, O
    Belghiti, J
    Kianmanesh, R
    Regimbeau, JM
    Santoro, R
    Vilgrain, V
    Denys, A
    Sauvanet, A
    [J]. ANNALS OF SURGERY, 2003, 237 (02) : 208 - 217